serine/threonine Kinase 17a (STK17A) (N-Term) Peptide

Details for Product No. ABIN1382030, Supplier: Log in to see
Protein Name
  • STK17A
  • DRAK1
  • RDRAK1
  • serine/threonine kinase 17a
  • STK17A
  • stk17a
Protein Region
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see
Blocked Antibody anti-serine/threonine Kinase 17a (STK17A) (N-Term) antibody (ABIN1031360)
Characteristics 15 amino amino terminus of human DRAK1.
Research Area Signaling, Apoptosis/Necrosis
Application Notes DRAK1 peptide is used for blocking the activity of DRAK1.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Sanjo, Kawai, Akira: "DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis." in: The Journal of biological chemistry, Vol. 273, Issue 44, pp. 29066-71, 1998 (PubMed).

Wesche, Korherr, Kracht, Falk, Resch, Martin: "The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)." in: The Journal of biological chemistry, Vol. 272, Issue 12, pp. 7727-31, 1997 (PubMed).

Hofmeister, Wiegmann, Korherr, Bernardo, Krönke, Falk: "Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein." in: The Journal of biological chemistry, Vol. 272, Issue 44, pp. 27730-6, 1997 (PubMed).